Hormones and asthma: scientists probe why women suffer more
NCT ID NCT01759186
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This research program investigates why severe asthma affects more women than men in adulthood, while the opposite is true in childhood. Researchers will study biological and chemical differences, including the role of menstrual cycles, to understand these patterns. The goal is to develop better tests to identify asthma types and track how the disease changes over time.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could lead to better diagnostic tests and personalized treatments for severe asthma based on gender and hormonal factors.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly result in new therapies, and findings may take years to translate into clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Start date
-
Dec 2012
- Expected to finish
-
Aug 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients living in the greater Cleveland area, and in Virginia
- Ages
-
6 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Subjects with asthma * children age 6-17 years old (25% enrollment) * adults 18 years and older (75% enrollment) Exclusion Criteria: * Pregnancy during the characterization phase * Current smoking * Smoking history \> 10 pack years if ≥30 years of age, or smoking history \> 5 pack years if \<30 years of age (Note: if a subject has a smoking history, no smoking within the past year), * Other chronic pulmonary disorders associated with asthma-like symptoms, including (but not limited to) cystic fibrosis, chronic obstructive pulmonary disease, chronic bronchitis, vocal cord dysfunction (that is the sole cause of respiratory symptoms and at the PI's discretion) * Severe scoliosis or chest wall deformities * History of premature birth before 35 weeks gestation * Unwillingness to receive an intramuscular triamcinolone acetonide injection.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Asthma are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Rainbow Babies and Children's Hospital
Cleveland, Ohio, 44106, United States
-
University of Virginia
Charlottesville, Virginia, 22908, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single triple inhaler tame asthma in the real world?
- Can a Three-Drug inhaler outperform the standard Two-Drug treatment for asthma?
- Can a new inhaler match Symbicort's performance?
- Fine-Mist inhalers aim to reach deep lungs in COPD
- Can a hormone supplement tame asthma?
- A wearable stethoscope may let kids with asthma monitor their lungs at home